nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0543	0.0543	CbGpPWpGaD
Felbamate—GRIN2A—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0484	0.0484	CbGpPWpGaD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0462	0.0462	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0446	0.0446	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0435	0.0435	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0411	0.0411	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0379	0.0379	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.037	0.037	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0327	0.0327	CbGpPWpGaD
Felbamate—GRIN2B—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.0321	0.0321	CbGpPWpGaD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0317	0.0317	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0278	0.0278	CbGpPWpGaD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0269	0.0269	CbGpPWpGaD
Felbamate—GRIN2A—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.0261	0.0261	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—KCNJ5—adrenal gland cancer	0.0251	0.0251	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.024	0.024	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.0222	0.0222	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—KCNJ5—adrenal gland cancer	0.0213	0.0213	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.0204	0.0204	CbGpPWpGaD
Felbamate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.02	0.02	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0167	0.0167	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.0165	0.0165	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—BAD—adrenal gland cancer	0.0156	0.0156	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0142	0.0142	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0135	0.0135	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—BAD—adrenal gland cancer	0.0133	0.0133	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0125	0.0125	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NR5A1—adrenal gland cancer	0.0118	0.0118	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CDC42—adrenal gland cancer	0.0118	0.0118	CbGpPWpGaD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0107	0.0107	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—PRKACA—adrenal gland cancer	0.00961	0.00961	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00899	0.00899	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BAD—adrenal gland cancer	0.00821	0.00821	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—PRKACA—adrenal gland cancer	0.00817	0.00817	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00764	0.00764	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MED12—adrenal gland cancer	0.00709	0.00709	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—adrenal gland cancer	0.00683	0.00683	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00676	0.00676	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0066	0.0066	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00628	0.00628	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—CDC42—adrenal gland cancer	0.00615	0.00615	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0059	0.0059	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—adrenal gland cancer	0.00581	0.00581	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00575	0.00575	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.0054	0.0054	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BRAF—adrenal gland cancer	0.00518	0.00518	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00478	0.00478	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00455	0.00455	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BRAF—adrenal gland cancer	0.0044	0.0044	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CDC42—adrenal gland cancer	0.00439	0.00439	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0042	0.0042	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00369	0.00369	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00274	0.00274	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00254	0.00254	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.00227	0.00227	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00222	0.00222	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNB1—adrenal gland cancer	0.00201	0.00201	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00189	0.00189	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—adrenal gland cancer	0.0016	0.0016	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.00146	0.00146	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000842	0.000842	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000796	0.000796	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000753	0.000753	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000679	0.000679	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000679	0.000679	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000645	0.000645	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000633	0.000633	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000614	0.000614	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.0006	0.0006	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000506	0.000506	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000498	0.000498	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000488	0.000488	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000434	0.000434	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000369	0.000369	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000347	0.000347	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000335	0.000335	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000299	0.000299	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000294	0.000294	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000267	0.000267	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000202	0.000202	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000161	0.000161	CbGpPWpGaD
